PEGARI, NCT00221624: Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients |
|
|
| Completed | 3 | 131 | Europe | Peginterferon alfa-2a, ribavirin, amantadine | University Hospital, Bordeaux, Hoffmann-La Roche | HCV Infection, Hepatitis C, Chronic | | 04/04 | | |
NCT00538811: Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders |
|
|
| Completed | 2/3 | 40 | RoW | interferon alpha-2b, ribavirin, interferon-gamma,, interferon alpha-2b, ribavirin, amantadine | Aga Khan University | Hepatitis C, Genotype 3, Non-responders, Relapsers | | | | |
